TAK-733

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-733, covering 2013-07-02 to 2013-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies [Phase 1]

See pricing